Nina Kottler, MD, associate CMO for clinical AI at Radiology Partners, explains the movement toward greater regulation of artificial intelligence and the need to test for bias. 

It is estimated that the demand for contrast-enhanced imaging could double over the next decade. 

New research suggests more women with late-stage breast cancer may develop brain metastases than previously believed. 

Recommendations for additional imaging are routinely included in radiology reports but are sometimes overlooked or not communicated in a timely manner. Experts believe large language models can help address these lapses in care. 

If approved, the two agents could offer providers greater insight into the process of patients’ neurodegeneration.

Realheart celebrated the news, noting that multiple preclinical trials focused on the technology's safety and effectiveness are currently underway.

The healthcare market analysis firm Signify Research released a list of predictions in radiology its analysts expect to see in 2025. 

Journavax was shown in clinical trials to be safe and effective, with no addictive potential.